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Abstract
Background: Recent reports using administrative claims data suggest the incidence of community- and hospital-onset
sepsis is increasing. Whether this reflects changing epidemiology, more effective diagnostic methods, or changes in
physician documentation and medical coding practices is unclear.
Methods: We performed a temporal-trend study from 2008 to 2012 using administrative claims data and patient-level
clinical data of adult patients admitted to Barnes-Jewish Hospital in St. Louis, Missouri. Temporal-trend and annual
percent change were estimated using regression models with autoregressive integrated moving average errors.
Results: We analyzed 62,261 inpatient admissions during the 5-year study period. ‘Any SIRS’ (i.e., SIRS on a single
calendar day during the hospitalization) and ‘multi-day SIRS’ (i.e., SIRS on 3 or more calendar days), which both use
patient-level data, and medical coding for sepsis (i.e., ICD-9-CM discharge diagnosis codes 995.91, 995.92, or 785.52)
were present in 35.3 %, 17.3 %, and 3.3 % of admissions, respectively. The incidence of admissions coded for sepsis
increased 9.7 % (95 % CI: 6.1, 13.4) per year, while the patient data-defined events of ‘any SIRS’ decreased by 1.8 %
(95 % CI: −3.2, −0.5) and ‘multi-day SIRS’ did not change significantly over the study period. Clinically-defined sepsis
(defined as SIRS plus bacteremia) and severe sepsis (defined as SIRS plus hypotension and bacteremia) decreased at
statistically significant rates of 5.7 % (95 % CI: −9.0, −2.4) and 8.6 % (95 % CI: −4.4, −12.6) annually. All-cause mortality,
SIRS mortality, and SIRS and clinically-defined sepsis case fatality did not change significantly during the study period.
Sepsis mortality, based on ICD-9-CM codes, however, increased by 8.8 % (95 % CI: 1.9, 16.2) annually.
Conclusions: The incidence of sepsis, defined by ICD-9-CM codes, and sepsis mortality increased steadily without a
concomitant increase in SIRS or clinically-defined sepsis. Our results highlight the need to develop strategies to
integrate clinical patient-level data with administrative data to draw more accurate conclusions about the
epidemiology of sepsis.
Background
Sepsis is a clinical syndrome characterized by a dys-
regulated systemic inflammatory response to an infec-
tion that may be complicated by one or more organ
dysfunctions, which is termed severe sepsis. Sepsis is
a significant cause of morbidity and mortality among
hospitalized patients. It is estimated that upwards of
one million persons in the United States develop sep-
sis each year, with an associated mortality of approxi-
mately 30 % [1, 2]. The financial costs associated with
sepsis care have been estimated to be between
$20,000 and $30,000 per case [1]. Estimates of the fre-
quency of sepsis are important for public health strategic
planning and prioritization of resources to reduce the bur-
den of disease; however, most sepsis surveillance reports
have relied on inpatient administrative claims data.
National efforts are focused on improving outcomes in pa-
tients with sepsis and hospital associated sepsis rates have
been proposed as a quality of care indicator [3, 4]. Modest
success reducing sepsis mortality was achieved in some
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studies with the implementation of the Surviving Sepsis
Campaign bundle; however, mortality due to sepsis is still
high [5, 6].
Definitions for the systemic inflammatory response
syndrome (SIRS) and sepsis were originally agreed upon
at a consensus conference in 1991 and have been revis-
ited several times to refine how the continuum of sepsis
is described [7]. Over the last 20 years, several studies
reported national trends in the incidence of sepsis, using
International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) discharge diagnosis
codes using large inpatient hospital administrative claims
datasets [2, 8, 9]. Based on this type of data, estimates of
the incidence of severe sepsis, clinically defined as syn-
drome of infection plus end-organ dysfunction, have
ranged from 303 to 1,074 cases per 100,000 population
[1]. The incidence of severe sepsis in these studies in-
creased between 8 · 2 to 13 · 3 % annually in the last 15
to 20 years [2, 8, 10]. A major limitation of the under-
lying data in these studies is that diagnosis codes have
not been correlated with clinical measurements, such as
vital sign measurements, laboratory tests, and microbio-
logical data. The few epidemiological studies of sepsis
that included clinical information did not examine
trends over time and were limited by factors such as
short study durations, restriction to intensive care unit
(ICU) patients, and single center design [11–13].
Given the ongoing debate surrounding the incidence
of sepsis in the United States and potential changes in
coding practices over time, the purpose of this study was
to characterize temporal trends in sepsis incidence, based
on administrative claims data at a large, Midwestern, ter-
tiary care hospital, and compare these administrative
claims data with clinical data in order to better understand
the trends in SIRS, sepsis and sepsis mortality over time.
Methods
Study setting and patient population
Barnes-Jewish Hospital (BJH) is a 1250-bed, academic,
tertiary-care center located in St. Louis, Missouri, USA,
which is affiliated with Washington University School of
Medicine. Approximately 50,000 patients are admitted
to BJH each year. BJH has six adult intensive care units,
plus newborn and special care nurseries. We included all
adults (≥18 years old) admitted to BJH within the first
week of each month between January 1, 2008 and De-
cember 31, 2012. Data on individual patients admitted
to the hospital during this time frame were obtained
from the medical informatics system, a relational data-
base which includes all vital sign measurements, labora-
tory tests, blood culture results, admission and discharge
dates, discharge ICD-9-CM diagnoses codes, and dis-
charge status (e.g., death, discharge to home).
Definitions
Clinical parameters
The systemic inflammatory response syndrome (SIRS)
was based on the criteria by Bone et al. and was defined
as the presence of at least two of four criteria occurring
on a given calendar day - heart rate (>90 beats/min);
respiratory rate (>20 breaths/min); temperature
(>38 · 3 or <36 °C); and white blood cell count
(>12,000 or <4,000 microL−1) [3, 7]. In order to minimize
the proportion of patients that transiently met SIRS cri-
teria (e.g., a post-operative patient in pain with a single
measurement of tachypnea and tachycardia), at least two
subsequent measurements for any of the three vital sign
criteria had to be outside the normal range on a given cal-
endar day in order to be counted towards SIRS (i.e., pa-
tients who had only a single out-of-range measurement
would therefore not be counted as SIRS). Although
blood samples for laboratory testing may drawn once
or many times daily, we accepted a single abnormal
white blood cell count measurement in a calendar day
to define SIRS. We defined patients with “any SIRS” as
meeting the above definition of SIRS on at least a single
calendar day during the hospitalization and patients
with “multi-day SIRS” as meeting SIRS criteria on three
or more (consecutive or non-consecutive) calendar
days. “Any SIRS” and “multi-day SIRS” are not mutually
exclusive.
We determined if patients had “SIRS plus hypotension”,
if they had a systolic blood pressure <90 mmHg within a
calendar day of the SIRS event. SIRS plus bacteremia
(within a calendar day of the SIRS event) was defined as
“sepsis” by clinical parameters. SIRS plus hypotension
combined with bacteremia (within a calendar day of the
SIRS event) was classified as “severe sepsis” by clinical pa-
rameters (Table 1). It should be noted that these defini-
tions are reflecting sepsis or severe sepsis with confirmed
bacteremia, which represents a fraction of all sepsis cases.
Bacteremia was defined as the first positive blood
culture within a calendar day of a SIRS event. Common
skin contaminants were excluded (i.e., Coagulase-negative
staphylococci, Micrococcus spp., Propionibacterium spp.,
Bacillus spp., Corynebacterium spp.).
Medical coding
We defined sepsis as occurring during a patient’s
hospitalization if the ICD-9-CM discharge diagnosis
codes included sepsis (995 · 91), severe sepsis (995 · 92),
or septic shock (785 · 52). We also compared this coding
algorithm for sepsis to two previously published sepsis
coding algorithms by Angus et al. and Dombrovskiy
et al., which both used administrative claims data [2, 8].
Finally, the Charlson comorbidity index, a weighted sum
of 19 comorbid conditions based on ICD-9-CM codes,
was calculated for each patient [14].
Thomas et al. BMC Anesthesiology  (2015) 15:169 Page 2 of 9
Statistical analyses
We calculated monthly incidence rates for sepsis (by
ICD-9-CM codes), sepsis (SIRS plus bacteremia), severe
sepsis (SIRS plus hypotension plus bacteremia), SIRS
plus hypotension, any SIRS, multi-day SIRS, and
bacteremia per 1,000 patient-days (Table 3). Mortality
rates associated with any SIRS, multi-day SIRS, sepsis,
and all-cause mortality as well as any SIRS, multi-day
SIRS, and sepsis fatality rates were also determined. The
proportion of patients with a Charlson comorbidity
score ≥5 in each month (to understand if the inpatient
population’s level of medical complexity changed) and
monthly average number of discharge diagnosis codes were
also calculated. Linear temporal-trend models were fitted
to the natural logarithm of each rate through dynamic re-
gression modeling. This was done to account for substan-
tial correlation in the corresponding residuals over time.
We accounted for the autocorrelation of residuals through
autoregressive integrated moving average (ARIMA) model-
ing, using regression models with ARIMA errors.
Annual percentage change (APC) in rates and pro-
portions was calculated from the estimated trends as:
APC = [eintercept + coefficient (month + 12) - eintercept + coefficient
(month)] / eintercept + coefficient (month) * 100, where intercept
and coefficient are estimated from the corresponding
models for each series [15]. All analyses were performed
in R software (R Foundation for Statistical Computing,
Vienna, Austria) [16].
The institutional review board of the Washington
University Human Research Protection Office (IRB#
201304071) approved the research protocol with a wai-
ver of written informed consent.
Results
Patient characteristics/demographics
The total number of patients who were admitted during
the first week of each month from 2008 to 2012 was
62,261 and represented 327,205 patient-days. The median
age (years, interquartile range) for all study patients, pa-
tients with any SIRS, multi-day SIRS, and for those pa-
tients coded for sepsis were 55 · 0 (41, 67), 56 · 0 (42, 68),
59 · 0 (46, 69), and 60 · 0 (50, 71), respectively. The racial
composition was predominantly white (62 · 6 %) and
African American (34 · 4 %) with a minority being
Asian/Pacific Islander or Native American (0 · 9 %). The
median length of hospital stay for all the study patients
was 3 · 0 days (range, 2 · 0, 6 · 0), and was progressively
longer for patients with any SIRS, multi-day SIRS, and
for patients coded for sepsis (Table 2). Admission to an
ICU during the hospital course (at any time) occurred
in 16 · 7 % of all patients admitted to the hospital. A
majority (74 %) of patients who were subsequently
coded for sepsis were admitted to an ICU (at any time)
during the hospital course.
Temporal trends for SIRS and sepsis
The incidence of sepsis based on administrative coding
increased at a statistically significant annual rate of 9 ·
7 % (95 % Confidence Interval (CI): 6 · 1, 13 · 4) during
the study period, similar to the coding algorithms
established by Angus and Dombrovskiy, which showed
significant upward trends with an annual percent
change of 5 · 8 % (95 % CI: 4 · 0, 7 · 5) and 5 · 5 % (95 %
CI: 3 · 4, 7 · 6), respectively. In contrast, the annual percent
change for any SIRS was −1 · 8 % (95 % CI: −3 · 2, −0 · 5)
Table 1 Variable explanations
Variable Comment Type
SIRS Uses the Surviving Sepsis Campaign [3] definition of the systemic inflammatory
response syndrome. At least two vital sign measurements were required
outside the range on a given calendar day (for each of the three vital
signs: temperature, heart rate, and respiratory rate).
Patient-level
Sepsis Defined by one of the following ICD-9 codes: 995 · 91, 995 · 92, 785 · 52 Administrative
Sepsis (Angus) Defined using the ICD-9 codes outlined in Angus et al., Crit Care Med.
2001;29 (7):1303–1310
Administrative
Sepsis (Dombrovskiy) Defined using the ICD-9 codes outlined in Dombrovskiy et al., Crit Care Med.
2007;35 (5):1244–1250
Administrative
Sepsis SIRS plus bacteremia (within a calendar day of SIRS event) Patient-level
Severe sepsis SIRS plus Hypotension (Systolic blood pressure <90 mmHg, occurring within
a calendar day of the SIRS event) + Bacteremia
Patient-level
SIRS plus hypotension SIRS plus Hypotension Patient-level
Any SIRS SIRS on a single calendar day during the hospitalization Patient-level
Multi-day SIRS SIRS on 3 or more calendar days Patient-level
Bacteremia First positive blood culture within a calendar day of a SIRS event. Common skin
contaminants were excluded (Coagulase-negative staphylococci, Micrococcus spp,
Propionibacterium acnes, Bacillus spp, Corynebacterium spp.).
Patient-level
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Table 2 Characteristics of patients in the study population
Characteristic All N = 62,261 Any SIRS
N = 21,962
Multi-day SIRS
N = 10,759
SIRS plus bacteremia
N = 1,412
SIRS plus hypotension
N = 2,026
SIRS plus hypotension and bacteremia
N = 193
Coded for sepsis
N = 2,062
Age [IQR] 55.0 [41.0, 67.0] 56.0 [42.0, 68.0] 59.0 [46.0, 69.0] 58.5 [48.0, 68.0] 59.0 [48.0, 70.0] 59.0 [49.5, 68.0] 60.0 [49.75, 71.0]
Male sex (%) 28,506 (45.8) 10,526 (47.9) 5,515 (51.3) 766 (54.2) 1,006 (49.7) 100 (51.8) 1,107 (53.7)
Race
- White (%) 39,004 (34.4) 14,382 (65.5) 7,453 (69.3) 910 (64.4) 1,467 (72.4) 123 (63.7) 1,370 (66.4)
- African American, Black (%) 21,420 (34.4) 6,943 (31.6) 3,030 (28.2) 459 (32.5) 493 (24.3) 59 (30.6) 626 (30.4)
- Asian, PI/NA (%) 580 (0.9) 211 (1.0) 94 (0.9) 19 (1.4) 25 (1.2) 4 (2.0) 27 (1.3)
- Other, unknown (%) 1,257 (2.0) 426 (1.9) 182 (1.7) 24 (1.7) 41 (2.0) 9 (4.6) 39 (1.9)
Length of stay [IQR] 3.0 [2.0, 6.0] 6.0 [3.0, 11.0] 10.0 [6.0, 17.0] 13.0 [6.0, 25.0] 7.0 [4.0, 13.0] 13.0 [5.0, 24.5] 11.0 [5.0, 21.25]
ICU admission (%) 10,377 (16.7) 8,193 (37.3) 5,634 (52.4) 815 (57.7) 1,267 (62.5) 151 (78.2) 1,521 (73.8)
In-hospital all-cause mortality (%) 1,715 (2.8) 1,535 (7.0) 1,023 (9.5) 292 (20.7) 328 (16.2) 58 (30.1) 654 (31.7)
SIRS: Systemic Inflammatory Response Syndrome; sepsis ICD-9-CM codes: 995 · 91, 995 · 92 and 785 · 52; IQR: Inter-quartile range for the corresponding median; PI/NA: Pacific Islander, Native American; ICU: intensive
care unit
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and the rate of multi-day SIRS did not significantly change
at all (−0 · 1 %; 95 % CI: −1 · 7, 1 · 5) (Table 3).
Sepsis (SIRS plus bacteremia) decreased at a statistically
significant rate of 5 · 7 % (−5 · 7; 95 % CI: −9 · 0, −2 · 4) over
the entire study period. SIRS plus hypotension and severe
sepsis, which were both also calculated using patient-level
data, decreased at statistically significant rates of 9 · 7 %
(−9 · 7; 95 % CI: −16 · 1, −2 · 9) and 8 · 6 % (−8 · 6;
95 % CI: −4 · 4, −12 · 6), respectively, from August
2009 to December 2012 (Note: blood pressure readings
were not available in the informatics database between
January 2008 and July 2009).
Temporal trends in mortality
All-cause hospital mortality among the entire patient
sample was 2 · 8 %. The mortality associated with sepsis
(by ICD-9 coding) showed an annual increase of 8 · 8 %
(95 % CI: 1 · 9, 16 · 2) during the study period. The same
was found for sepsis mortality as defined by the
Angus method, which showed an increase of 10 · 0 %
Table 3 Annual percent change and estimates of linear temporal trends for (the natural logarithm of) rates of sepsis, SIRS,
bacteremia, sepsis-related mortality, SIRS-related mortality, overall hospital mortality and average coding
Trend coefficient (95 % CI) Annual percent change (95 % CI)
Coding variables
Sepsis 0 · 0077 (0 · 0049, 0 · 0105)a 9 · 7 (6 · 1, 13 · 4)
Sepsis (Angus) 0 · 0047 (0 · 0033, 0 · 0060)a 5 · 8 (4 · 0, 7 · 5)
Sepsis (Dombrovskiy) 0 · 0044 (0 · 0028, 0 · 0061)a 5 · 5 (3 · 4, 7 · 6)
Sepsis mortality 0 · 0070 (0 · 0015, 0 · 0125)a 8 · 8 (1 · 9, 16 · 2)
Sepsis mortality (Angus) 0 · 0080 (0 · 0015, 0 · 0145)a 10 · 0 (1 · 8, 18 · 9)
Sepsis mortality (Dombrovskiy) 0 · 0051 (−0 · 0007, 0 · 0110) 6 · 3 (−0 · 8, 14 · 1)
Sepsis fatality −0 · 0004 (−0 · 0065, 0 · 0057) −0 · 5 (−7 · 5, 7 · 0)
Sepsis fatality (Angus) 0 · 0026 (−0 · 0019, 0 · 0072) 3 · 2 (−2 · 2, 9 · 0)
Sepsis fatality (Dombrovskiy) 0 · 0010 (−0 · 0046, 0 · 0066) 1 · 2 (−5 · 4, 8 · 2)
Sepsis & Charlson ≥5 0 · 0073 (0 · 0035, 0 · 0111)a 9 · 1 (4 · 3, 14 · 2)
Sepsis & ICU 0 · 0075 (0 · 0046, 0 · 0104)a 9 · 4 (5 · 7, 13 · 3)
ICU & Charlson ≥5 −0 · 0011 (−0 · 0051, 0 · 0029) −1 · 3 (−5 · 9, 3 · 6)
Average coding 0 · 0128 (0 · 0110, 0 · 0147)a 16 · 6 (14 · 1, 19 · 3)
Clinical variables
Sepsis −0 · 0049 (−0 · 0079, −0 · 0020)a −5 · 7 (−9 · 0, −2 · 4)
Severe sepsis −0 · 0075 (−0 · 0112, −0 · 0038)a −8 · 6 (−4 · 4, −12 · 6)
SIRS plus hypotension −0 · 0085 (−0 · 0146, −0 · 0025)a −9 · 7 (−16 · 1, −2 · 9)
Any SIRS −0 · 0015 (−0 · 0027, −0 · 0004)a −1 · 8 (−3 · 2, −0 · 5)
Multi-day SIRS −0 · 0001 (−0 · 0014, 0 · 0013) −0 · 1 (−1 · 7, 1 · 5)
Bacteremia −0 · 0055 (−0 · 0083, −0 · 0026)a −6 · 3 (−9 · 5, −3 · 1)
All-cause mortality −0 · 0005 (−0 · 0035, 0 · 0025) −0 · 6 (−4 · 1, 3 · 0)
Sepsis mortality −0 · 0063 (−0 · 0098, −0 · 0027)a −7 · 3 (−11 · 1, −3 · 2)
Severe sepsis mortality −0 · 0019 (−0 · 0055, 0 · 0018) −2 · 2 (−6 · 4, 2 · 1)
SIRS plus hypotension mortality −0 · 0111 (−0 · 0260, 0 · 0037) −12 · 5 (−26 · 8, 4 · 6)
Any SIRS mortality 0 · 0005 (−0 · 0027, 0 · 0037) 0 · 6 (−3 · 2, 4 · 5)
Multi-day SIRS mortality 0 · 0013 (−0 · 0035, 0 · 0061) 1 · 5 (−4 · 2, 7 · 5)
Sepsis fatality 0 · 0016 (−0 · 0047, 0 · 0079) 1 · 9 (−5 · 5, 10 · 0)
Severe sepsis fatality −0 · 0048 (−0 · 0377, 0 · 0280) −5 · 6 (−36 · 4, 40 · 0)
SIRS plus hypotension fatality −0 · 0051 (−0 · 0104, 0 · 0003) −5 · 9 (−11 · 8, 0 · 4)
Any SIRS fatality 0 · 0021 (−0 · 0011, 0 · 0052) 2 · 5 (−1 · 3, 6 · 4)
Multi-day SIRS fatality 0 · 0007 (−0 · 0027, 0 · 0041) 0 · 8 (−3 · 2, 5 · 0)
aThe confidence interval does not include 0
Note: ICU – Intensive Care Unit; SIRS – Systemic Inflammatory Response Syndrome; Sepsis (coding variable) = 995 · 91, 995 · 92, 785 · 52; Sepsis (clinical variable) = SIRS
plus bacteremia; Severe sepsis (clinical variable) = SIRS plus hypotension plus bacteremia
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(95 % CI: 1 · 8, 18 · 9) per year. Sepsis mortality
(defined using clinical criteria) showed a statistically
significant decrease at 7 · 3 % per year (95 % CI:
(−11 · 1, −3 · 2). All-cause hospital mortality was high-
est for those coded for sepsis (31 · 7 %), followed by
those with multi-day SIRS (9 · 5 %) and any SIRS
(7 · 0 %). The sepsis case fatality rate did not show
a statistically significant change over time using all
three administrative data based algorithms of sepsis
(ICD-9, Angus, and Dombrovskiy) or by clinical
criteria (Fig. 1). SIRS plus hypotension mortality, se-
vere sepsis mortality, and the corresponding case
fatality rates did not change significantly over the
study period. Additionally, the SIRS mortality rates
and SIRS case fatality rates did not show a statisti-
cally significant change over time (Table 3).
Temporal trends in coding, bacteremia, and severity of
illness
The average number of discharge diagnosis codes
per admission increased by 16 · 6 % (95 % CI: 14 · 1,
19 · 3) during each year of the study period (Fig. 2).
The subset of patients with a Charlson comorbidity
score ≥5 did not change significantly over the study
period while the proportion of patients with a Charl-
son score ≥5 and who were coded for sepsis in-
creased by 9 · 1 % per year (95 % CI: 4 · 3, 14 · 2).
Additionally, sepsis coding among ICU patients in-
creased at 9 · 4 % per year (95 % CI: 5 · 7, 13 · 3). The
rate of bacteremia, among all patients, decreased
steadily by 6 · 3 % (−6 · 3; 95 % CI: −9 · 5, −3 · 1)
annually.
Discussion
At our institution, the incidence of sepsis, based on ad-
ministrative claims data, increased by 9 · 7 % annually
during the study period, which is consistent with other
studies that have used administrative claims data to re-
port sepsis incidence [2, 8, 9]. However, we did not see a
concomitant increase in patient-level variables associated
with sepsis. For example, there was no significant
increase in the systemic inflammatory response syn-
drome (SIRS); SIRS events even decreased slightly over
the study period. The rate of positive blood cultures
(bacteremia being one of the predominant causes of
sepsis) also trended downwards over time. Moreover, the
patient-level information used as a proxy marker for se-
vere sepsis (i.e., SIRS plus hypotension) and employed in
our definition of sepsis (SIRS plus bacteremia) and severe
sepsis (SIRS plus bacteremia and hypotension) yielded
decreasing rates over time. We hypothesize that increas-
ingly accurate documentation of sepsis in the medical
record has resulted in improved administrative coding
for sepsis and other medical conditions. There has also
been an overall increase in the number of discharge
diagnosis codes among hospitalized patients, which may
reflect better documentation and coding and/or increasing
prevalence of multiple comorbidities among hospitalized
patients. In addition, we suspect that the increase in sepsis
mortality among coded patients reflects more accurate
documentation of severity of illness and sepsis coding
practices than in the past.
Administrative claims data are a relatively cost effective
and readily available means of determining population in-
cidence and performing long-term surveillance for many
Fig. 1 Rates (per 1,000 patient-days) for Sepsis, Any SIRS, Multi-day SIRS, and All-Cause Mortality and Ratios (%) for Sepsis and SIRS Fatality
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diseases. However, because administrative claims data are
primarily used for billing and not for surveillance or re-
search, these data are susceptible to variation in physician
documentation and changes in coding practices. The qual-
ity and accuracy of physician documentation may vary
considerably and has therefore become the subject of
quality improvement initiatives, known as clinical docu-
mentation improvement (CDI), a [17]. It has been demon-
strated that patient admissions due to severe sepsis and
septic shock are often under-coded because of inadequate
documentation [18]. Also, several studies have reported
that the sensitivity and specificity of various coding ab-
straction methods perform poorly compared to structured
chart review [19–21].
While not focusing on sepsis specifically, studies of
other medical conditions have found that administrative
data coding practices change over time. A recent study
on hospitalizations and mortality in patients with pneu-
monia highlights how administrative claims coding is
susceptible to shifts in coding practices. Using the
National Inpatient Sample to examine temporal trends
in diagnostic coding for a principal diagnosis of pneu-
monia, sepsis with a secondary diagnosis of pneumonia,
or respiratory failure with a secondary diagnosis of
pneumonia, Lindenauer et al. found that the supposed
improvement in mortality from pneumonia did not
reflect improved patient outcomes but rather was a
function of variations in coding practices [22]. The
authors aptly noted in their discussion that the rapid in-
crease in sepsis and severe sepsis begs the question as to
whether the phenomenon of changing trends in coding
they saw in pneumonia is also happening more broadly
with sepsis. Our findings suggests this is the case, since
we saw a steady rate of increase in sepsis coding without
a concurrent increase in clinical events such as SIRS and
bacteremia that would be expected if there were a true
increase in sepsis incidence.
Our study is limited by its single center design, a rela-
tively short study period, and the lack of complete data for
blood pressure measurements in one of the study years.
Additionally, we cannot determine the reasons behind in-
creased medical coding for sepsis. Coding practices are
likely driven by a variety of factors. Administrative claims
data, primarily a tool for billing, rely on physician docu-
mentation, utilize surrogate markers (i.e., the codes) for
diseases and are not directly linked to more comprehen-
sive patient-level clinical data. The increased awareness of
sepsis syndromes and international efforts lead by the
Surviving Sepsis Campaign to improve sepsis care may
have heightened awareness and changed physician docu-
mentation practices [3]. One consequence of this is that
longitudinal studies conducted in the last decade, which
utilized administrative claims data to define sepsis, may
not accurately reflect the true epidemiology of commu-
nity- or healthcare-associated sepsis. Growing pressures
on hospital quality measurements, financial incentive pro-
grams (pay-for-performance), and the increase in elec-
tronic health records may have resulted in better
documentation of severity of illness by physicians and
hospitals [23, 24].
Conclusions
In conclusion, administrative claims data coding prac-
tices likely shift with changes in healthcare regulations
Fig. 2 Rates (per 1,000 patient-days) for Sepsis, Severe Sepsis, Any SIRS, Multi-day SIRS, Bacteremia, and Average Coding
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and variation in physician documentation. Coding for
sepsis, measured by administrative claims data, has in-
creased over time; however, in our institution the under-
lying rate of SIRS, SIRS plus hypotension, sepsis, and
severe sepsis, as measured using clinical data has
remained stable. Administrative data therefore do not
reflect clinical trends very well and our results highlight
the need to develop strategies to integrate clinical
patient-level data with administrative data to draw more
accurate conclusions about the epidemiology of sepsis.
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